About Abbott India Ltd
Abbott India is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.
Founded
1944
CEO
Munir Shaikh
Employees
3,749
HQ
Mumbai, India
Finished Products
1Sale of Products
₹22,786.73Cr2Excise Duty
₹6,382.04Cr3Service Income
₹190.54Cr4Other Operating Revenues
₹144.33Cr5Trade Discount
₹33.02Cr6Sale of Scrap
₹6.27Cr7Export incentives
₹0.34Cr1–7 of 8
Raw Materials
1Other (Purchase)
₹13,402.17Cr2Cost of Materials Consumed
₹2,854.74CrAbout Abbott India Ltd
Abbott India is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.
Founded:1944
CEO:Munir Shaikh
Employees:3,749
HQ:Mumbai, India
Finished Products
1Sale of Products
₹22,786.73Cr2Excise Duty
₹6,382.04Cr3Service Income
₹190.54Cr4Other Operating Revenues
₹144.33Cr5Trade Discount
₹33.02Cr6Sale of Scrap
₹6.27Cr7Export incentives
₹0.34Cr1–7 of 8
Raw Materials
1Other (Purchase)
₹13,402.17Cr2Cost of Materials Consumed
₹2,854.74CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹32,775
52W Low
₹25,150
Volume7.83K
Avg VolumeN/A
Beta0.29
Dividend Yield2.51%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
34.40x
Valuation
P/B Ratio
11.63x
Valuation
EPS
₹759.85
Valuation
Dividend Yield
2.51%
Valuation
ROE
32.51%
Profitability
ROCE
42.54%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
98.8%
International
1.2%
India98.8%
Outside India1.2%
Strategic Relations
Collaborations, joint ventures & subsidiaries
L
Lupharma GmbH
Germany
58.20% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.04x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
0.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.